ArriVent BioPharma (AVBP) Stock Chart & Stock Price History $21.08 +0.80 (+3.94%) Closing price 04/23/2025 04:00 PM EasternExtended Trading$21.06 -0.02 (-0.09%) As of 04/23/2025 04:19 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ArriVent BioPharma Stock Price Performance 5 Day Performance+16.21%1 Month Performance+4.30%3 Month Performance-22.78%6 Month Performance-32.04%Year-To-Date Performance-20.87%1 Year Performance+37.78% Receive AVBP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ArriVent BioPharma and its competitors with MarketBeat's FREE daily newsletter. Email Address AVBP Stock Chart for Thursday, April, 24, 2025 AVBP Chart by TradingView ArriVent BioPharma Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/23/2025$20.28$21.08+3.94%$21.63$20.58246,990 shs$717.06 million04/22/2025$19.54$20.28+3.79%$20.59$19.65148,397 shs$689.84 million04/21/2025$18.14$19.54+7.72%$19.69$17.43202,634 shs$664.67 million04/18/2025$18.14$18.14$18.42$17.37179,598 shs$617.05 million04/17/2025$17.90$18.14+1.34%$18.42$17.37179,598 shs$617.05 million04/16/2025$18.63$17.90-3.92%$18.62$17.72120,947 shs$608.89 million04/15/2025$18.39$18.63+1.31%$18.72$18.21142,944 shs$633.72 million04/14/2025$18.15$18.39+1.32%$18.69$17.73224,486 shs$625.55 million04/11/2025$16.86$18.15+7.65%$18.17$16.31281,325 shs$617.39 million04/10/2025$17.56$16.86-3.99%$17.30$16.16246,235 shs$597.32 million Get the Latest News and Ratings for AVBP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ArriVent BioPharma and its competitors with MarketBeat's FREE daily newsletter. 04/09/2025$16.30$17.56+7.73%$17.92$15.55343,211 shs$597.32 million04/09/2025$16.30$17.56+7.73%$17.92$15.55343,211 shs$597.32 million04/08/2025$16.61$16.30-1.87%$17.50$15.73304,974 shs$554.46 million04/08/2025$16.61$16.30-1.87%$17.50$15.73304,974 shs$554.46 million04/07/2025$16.42$16.61+1.16%$17.06$15.47199,190 shs$565.01 million04/04/2025$16.94$16.42-3.07%$16.80$15.53827,428 shs$558.54 million04/03/2025$18.00$16.94-5.89%$17.50$16.72340,473 shs$576.23 million04/02/2025$18.03$18.00-0.17%$18.46$17.79277,235 shs$612.29 million04/01/2025$18.49$18.03-2.49%$18.26$17.54305,172 shs$613.31 million03/31/2025$18.95$18.49-2.43%$18.94$17.83433,281 shs$628.96 million03/28/2025$18.57$18.95+2.05%$19.04$18.41121,155 shs$644.60 million03/27/2025$18.28$18.57+1.59%$18.75$17.89166,042 shs$631.68 million03/26/2025$18.99$18.28-3.74%$19.34$18.07186,785 shs$645.96 million03/25/2025$20.21$18.99-6.04%$20.15$18.58214,175 shs$645.96 million03/24/2025$19.52$20.21+3.53%$20.37$19.57131,400 shs$687.46 million Related Companies Xenon Pharmaceuticals Stock Chart MoonLake Immunotherapeutics Stock Chart Alvotech Stock Chart Immunovant Stock Chart HUTCHMED Stock Chart ACADIA Pharmaceuticals Stock Chart Apellis Pharmaceuticals Stock Chart Amneal Pharmaceuticals Stock Chart Recursion Pharmaceuticals Stock Chart ImmunityBio Stock Chart Receive AVBP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ArriVent BioPharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AVBP) was last updated on 4/24/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredThe Exact July Date the AI Correction Will End?AI stocks have cooled off—but Jeff Brown, the tech expert who picked Nvidia before it soared 222x, says one da...Brownstone Research | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | SponsoredThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ArriVent BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ArriVent BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AVBP Stock Free AVBP Stock Alerts